Phio Pharmaceuticals Corp. — SC 13G/A Filings
27 SC 13G/A filings on record
This page lists all SC 13G/A filings submitted to the SEC by Phio Pharmaceuticals Corp. (PHIO), sorted by most recent first. Each row links to the full filing on EdgarLookup. Phio Pharmaceuticals Corp. has filed 27 SC 13G/A documents with the SEC since 2011. To view all SEC filings by Phio Pharmaceuticals Corp., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
25-NSE
3
3/A
4
4/A
424B2
424B3
424B4
424B5
8-A12B
8-A12G
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
EFFECT
FWP
POS AM
POS EX
PRE 14A
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SP 15D2
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G/A | AMENDMENT NO. 5 TO SCHEDULE 13G | 0001213900-24-097266 | Nov 13, 2024 | — |
| SC 13G/A | AMENDMENT NO. 4 TO SCHEDULE 13G | 0001213900-24-010340 | Feb 6, 2024 | — |
| SC 13G/A | AMENDMENT NO. 3 TO SCHEDULE 13G | 0001213900-23-009116 | Feb 8, 2023 | — |
| SC 13G/A | AMEDMENT NO. 2 TO SCHEDULE 13G | 0001213900-22-006700 | Feb 11, 2022 | — |
| SC 13G/A | PHIO PHARMACEUTICALS CORP. | 0000902664-22-000373 | Jan 20, 2022 | — |
| SC 13G/A | SC 13G/A | 0001104659-21-023252 | Feb 16, 2021 | — |
| SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | 0001213900-21-005111 | Jan 29, 2021 | — |
| SC 13G/A | SABBY 13G-A PHIO 1.05.21 | 0001535610-21-000011 | Jan 5, 2021 | — |
| SC 13G/A | SC 13G/A | 0001104659-20-013419 | Feb 10, 2020 | — |
| SC 13G/A | SABBY 13G-A PHIO 1.22.20 | 0001535610-20-000054 | Jan 22, 2020 | — |
| SC 13G/A | SC 13G/A | 0001193125-19-040180 | Feb 14, 2019 | — |
| SC 13G/A | SC 13G/A | 0001104659-19-008571 | Feb 14, 2019 | — |
| SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | 0001213900-19-001926 | Feb 8, 2019 | — |
| SC 13G/A | SABBY 13G-A PHIO 1.04.19 | 0001535610-19-000030 | Jan 4, 2019 | — |
| SC 13G/A | — | 0000919574-17-001290 | Feb 13, 2017 | — |
| SC 13G/A | SABBY 13G-A RXII 1.12.17 | 0001535610-17-000065 | Jan 12, 2017 | — |
| SC 13G/A | AMENDMENT NO. 3 | 0001214659-16-009581 | Feb 16, 2016 | — |
| SC 13G/A | — | 0000919574-16-010372 | Feb 12, 2016 | — |
| SC 13G/A | SC 13G/A | 0001193125-16-452263 | Feb 5, 2016 | — |
| SC 13G/A | RXI PHARMACEUTICALS CORPORATION | 0000902664-16-004886 | Jan 19, 2016 | — |
| SC 13G/A | SABBY 13G-A RXII 1.13.16 | 0001535610-16-000120 | Jan 13, 2016 | — |
| SC 13G/A | — | 0001575872-15-000022 | Feb 25, 2015 | — |
| SC 13G/A | — | 0001575872-15-000021 | Feb 25, 2015 | — |
| SC 13G/A | AMENDMENT NO. 2 | 0001214659-15-000611 | Jan 27, 2015 | — |
| SC 13G/A | — | 0000919574-14-005454 | Oct 3, 2014 | — |
| SC 13G/A | — | 0000919574-14-001709 | Feb 14, 2014 | — |
| SC 13G/A | AMENDMENT NO. 1 | 0001214659-14-000376 | Jan 16, 2014 | — |